Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery
- PMID: 35992894
- PMCID: PMC9386849
- DOI: 10.1177/17562864221114357
Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery
Abstract
Seizures are a common symptom of craniocerebral diseases, and epilepsy is one of the comorbidities of craniocerebral diseases. However, how to rationally use anti-seizure medications (ASMs) in the perioperative period of craniocerebral surgery to control or avoid seizures and reduce their associated harm is a problem. The China Association Against Epilepsy (CAAE) united with the Trauma Group of the Chinese Neurosurgery Society, Glioma Professional Committee of the Chinese Anti-Cancer Association, Neuro-Oncology Branch of the Chinese Neuroscience Society, and Neurotraumatic Group of Chinese Trauma Society, and selected experts for consultancy regarding outcomes from evidence-based medicine in domestic and foreign literature. These experts referred to the existing research evidence, drug characteristics, Chinese FDA-approved indications, and expert experience, and finished the current guideline on the application of ASMs during the perioperative period of craniocerebral surgery, aiming to guide relevant clinical practice. This guideline consists of six sections: application scope of guideline, concepts of craniocerebral surgery-related seizures and epilepsy, postoperative application of ASMs in patients without seizures before surgery, application of ASMs in patients with seizures associated with lesions before surgery, emergency treatment of postoperative seizures, and 16 recommendations.
Keywords: anti-seizure medications (ASMs); craniocerebral surgery-related epilepsy; craniocerebral surgery-related seizure; guideline.
© The Author(s), 2022.
Conflict of interest statement
Competing Interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
References
-
- Yao Z, Hu X, You C. The incidence and treatment of seizures after cranioplasty: a systematic review and meta-analysis. Br J Neurosurg 2018; 32: 489–494. - PubMed
-
- Spencer R, Manivannan S, Sharouf F, et al.. Risk factors for the development of seizures after cranioplasty in patients that sustained traumatic brain injury: a systematic review. Seizure 2019; 69: 11–16. - PubMed
-
- National Neurosurgery Epilepsy Prevention and Treatment Cooperative Group. Guidelines for the prevention and treatment of perioperative and post-traumatic epilepsy in neurosurgery (Draft). Zhong Hua Shen Jing Ke Za Zhi 2006; 5: 1189–1192.
Publication types
LinkOut - more resources
Full Text Sources
